# Finerenone and Cardiac Remodeling

> **NCT07270367** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Subodh Verma** · enrollment: 156 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Finerenone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07270367
- **Lead sponsor:** Subodh Verma
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2025-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07270367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07270367, "Finerenone and Cardiac Remodeling". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07270367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*